<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26886455</PMID><DateCompleted><Year>2016</Year><Month>08</Month><Day>02</Day></DateCompleted><DateRevised><Year>2019</Year><Month>02</Month><Day>22</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>2</Issue><PubDate><Year>2016</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>siRNA Targeting the 2Apro Genomic Region Prevents Enterovirus 71 Replication In Vitro.</ArticleTitle><Pagination><StartPage>e0149470</StartPage><MedlinePgn>e0149470</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0149470</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0149470</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71) is the most important etiological agent of hand, foot, and mouth disease (HFMD) in young children, which is associated with severe neurological complications and has caused significant mortalities in recent HFMD outbreaks in Asia. However, there is no effective antiviral therapy against EV71. In this study, RNA interference (RNAi) was used as an antiviral strategy to inhibit EV71 replication. Three small interfering RNAs (siRNAs) targeting the 2Apro region of the EV71 genome were designed and synthesized. All the siRNAs were transfected individually into rhabdomyosarcoma (RD) cells, which were then infected with strain EV71-2006-52-9. The cytopathic effects (CPEs) in the infected RD cells, cell viability, viral titer, and viral RNA and protein expression were examined to evaluate the specific viral inhibition by the siRNAs. The results of cytopathogenicity and MTT tests indicated that the RD cells transfected with the three siRNAs showed slight CPEs and significantly high viability. The 50% tissue culture infective dose (TCID50) values demonstrated that the viral titer of the groups treated with three siRNAs were lower than those of the control groups. qRT-PCR and western blotting revealed that the levels of viral RNA and protein in the RD cells treated with the three siRNAs were lower than those in the controls. When RD cells transfected with siRNAs were also infected with strain EV71-2008-43-16, the expression of the VP1 protein was significantly inhibited. The levels of interferon &#x3b1; (IFN-&#x3b1;) and IFN-&#x3b2; did not differ significantly in any group. These results suggest that siRNAs targeting the 2Apro region of the EV71 genome exerted antiviral effects in vitro.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Haibing</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Yanyan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Immunology, Institute of Laboratory Medicine, Jiangsu University, Zhenjiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kong</LastName><ForeName>Zhenzhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Immunology, Institute of Laboratory Medicine, Jiangsu University, Zhenjiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shao</LastName><ForeName>Qixiang</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Immunology, Institute of Laboratory Medicine, Jiangsu University, Zhenjiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Zhaoliang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Immunology, Institute of Laboratory Medicine, Jiangsu University, Zhenjiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Shengjun</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jianguo</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>02</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034741">RNA, Small Interfering</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>9008-11-1</RegistryNumber><NameOfSubstance UI="D007372">Interferons</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001681" MajorTopicYN="N">Biological Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003588" MajorTopicYN="N">Cytopathogenic Effect, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019610" MajorTopicYN="N">Cytoprotection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016679" MajorTopicYN="Y">Genome, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007372" MajorTopicYN="N">Interferons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034622" MajorTopicYN="N">RNA Interference</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034741" MajorTopicYN="N">RNA, Small Interfering</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014162" MajorTopicYN="N">Transfection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing Interests: </b>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>2</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26886455</ArticleId><ArticleId IdType="pmc">PMC4757562</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0149470</ArticleId><ArticleId IdType="pii">PONE-D-15-31670</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Shih SR, Stollar V, Li ML. Host Factors in Enterovirus 71 Replication. Journal of Virology. 2011;85(19):9658&#x2013;66. 10.1128/jvi.05063-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.05063-11</ArticleId><ArticleId IdType="pmc">PMC3196451</ArticleId><ArticleId IdType="pubmed">21715481</ArticleId></ArticleIdList></Reference><Reference><Citation>Yip CCY, Lau SKP, Woo PCY, Yuen K-Y. Human enterovirus 71 epidemics: what's next? Emerging Health Threats Journal. 2013;6(0). 10.3402/ehtj.v6i0.19780</Citation><ArticleIdList><ArticleId IdType="doi">10.3402/ehtj.v6i0.19780</ArticleId><ArticleId IdType="pmc">PMC3772321</ArticleId><ArticleId IdType="pubmed">24119538</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Zou G, Xia A, Wang X, Cai J, Gao Q, et al. Enterovirus 71 infection in children with hand, foot, and mouth disease in Shanghai, China: epidemiology, clinical feature and diagnosis. Virology Journal. 2015;12(1):83 10.1186/s12985-015-0308-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-015-0308-2</ArticleId><ArticleId IdType="pmc">PMC4464242</ArticleId><ArticleId IdType="pubmed">26036928</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S-M, Lei H-Y, Liu C-C. Cytokine Immunopathogenesis of Enterovirus 71 Brain Stem Encephalitis. Clinical and Developmental Immunology. 2012;2012:1&#x2013;8. 10.1155/2012/876241</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/876241</ArticleId><ArticleId IdType="pmc">PMC3432373</ArticleId><ArticleId IdType="pubmed">22956971</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu Y-F, Lin C-H, Lee H-T, Yan J-J, Sze C-I, Chou Y-P, et al. Elevated cerebrospinal fluid endothelin 1 associated with neurogenic pulmonary edema in children with enterovirus 71 encephalitis. International Journal of Infectious Diseases. 2015;34:105&#x2013;11. 10.1016/j.ijid.2015.03.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2015.03.017</ArticleId><ArticleId IdType="pubmed">25820093</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng X, Guan W, Guo Y, Yu H, Zhang X, Cheng R, et al. A novel recombinant lineage&#x2019;s contribution to the outbreak of coxsackievirus A6-associated hand, foot and mouth disease in Shanghai, China, 2012&#x2013;2013. Scientific Reports. 2015;5:11700 10.1038/srep11700</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep11700</ArticleId><ArticleId IdType="pmc">PMC4485158</ArticleId><ArticleId IdType="pubmed">26121916</ArticleId></ArticleIdList></Reference><Reference><Citation>Ang LW, Koh BK, Chan KP, Chua LT, James L, Goh KT. Epidemiology and control of hand, foot and mouth disease in Singapore. Ann Acad Med Singapore. 2009;38:106&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">19271036</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Zhu Z, Yang W, Ren J, Tan X, Wang Y, et al. An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China. Virology journal. 2010;7(1):94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2885340</ArticleId><ArticleId IdType="pubmed">20459851</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannon GJ. RNA interference. nature. 2002;418(6894):244&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">12110901</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramachandran PV, Ignacimuthu S. RNA Interference&#x2014;A Silent but an Efficient Therapeutic Tool. Applied Biochemistry and Biotechnology. 2013;169(6):1774&#x2013;89. 10.1007/s12010-013-0098-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12010-013-0098-1</ArticleId><ArticleId IdType="pubmed">23340870</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharp PA. RNA interference&#x2014;2001. Genes &amp; development. 2001;15(5):485&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">11238371</ArticleId></ArticleIdList></Reference><Reference><Citation>Luan Y, Dai H-L, Yang D, Zhu L, Gao T-L, Shao H-J, et al. Small interfering RNA against the 2C genomic region of coxsackievirus B3 exerts potential antiviral effects in permissive HeLa cells. Virus Research. 2012;163(1):183&#x2013;9. 10.1016/j.virusres.2011.09.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2011.09.016</ArticleId><ArticleId IdType="pubmed">21945637</ArticleId></ArticleIdList></Reference><Reference><Citation>Kossida S, Vlachakis D, Tsiliki G, Pavlopoulou A, Roubelakis M, Champeris Tsaniras S. Antiviral Stratagems Against HIV-1 Using RNA Interference (RNAi) Technology. Evolutionary Bioinformatics. 2013:203 10.4137/ebo.s11412</Citation><ArticleIdList><ArticleId IdType="doi">10.4137/ebo.s11412</ArticleId><ArticleId IdType="pmc">PMC3662398</ArticleId><ArticleId IdType="pubmed">23761954</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen W-H, Liu J-Y, Qin W-J, Zhao J, Wang T, Jia L-T, et al. Targeted inhibition of HBV gene expression by single-chain antibody mediated small interfering RNA delivery. Hepatology. 2007;46(1):84&#x2013;94. 10.1002/hep.21663</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.21663</ArticleId><ArticleId IdType="pubmed">17596868</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, Yang F, Zhao R, Zhao L, Guo D, Jin Q. Identification of small interfering RNAs which inhibit the replication of several Enterovirus 71 strains in China. Journal of Virological Methods. 2009;159(2):233&#x2013;8. 10.1016/j.jviromet.2009.04.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2009.04.002</ArticleId><ArticleId IdType="pubmed">19490979</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim ACN, Luhur A, Tan TMC, Chow VTK, Poh CL. RNA interference against enterovirus 71 infection. Virology. 2005;341(1):72&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">16083932</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu W-W, Hsu Y-Y, Yang J-Y, Kung S-H. Selective inhibition of enterovirus 71 replication by short hairpin RNAs. Biochemical and Biophysical Research Communications. 2004;325(2):494&#x2013;9. 10.1016/j.bbrc.2004.10.062</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2004.10.062</ArticleId><ArticleId IdType="pubmed">15530419</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng J-X, Nie X-J, Lei Y-F, Ma C-F, Xu D-L, Li B, et al. The highly conserved 5'untranslated region as an effective target towards the inhibition of Enterovirus 71 replication by unmodified and appropriate 2'-modified siRNAs. Journal of biomedical science. 2012;19(1):1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3438048</ArticleId><ArticleId IdType="pubmed">22889374</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Q, Yameen M, Liu W, Gao Z, Li Y, Peng X, et al. Conformational Plasticity of the 2A Proteinase from Enterovirus 71. Journal of Virology. 2013;87(13):7348&#x2013;56. 10.1128/jvi.03541-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.03541-12</ArticleId><ArticleId IdType="pmc">PMC3700279</ArticleId><ArticleId IdType="pubmed">23616646</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo RL, Kung SH, Hsu YY, Liu WT. Infection with enterovirus 71 or expression of its 2A protease induces apoptotic cell death. J Gen Virol. 2002;83(Pt 6):1367&#x2013;76. Epub 2002/05/25. .</Citation><ArticleIdList><ArticleId IdType="pubmed">12029152</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan Y-F, Sam I, AbuBakar S. Phylogenetic designation of enterovirus 71 genotypes and subgenotypes using complete genome sequences. Infection, Genetics and Evolution. 2010;10(3):404&#x2013;12. 10.1016/j.meegid.2009.05.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2009.05.010</ArticleId><ArticleId IdType="pubmed">19465162</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornung V, Guenthner-Biller M, Bourquin C, Ablasser A, Schlee M, Uematsu S, et al. Sequence-specific potent induction of IFN-&#x3b1; by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nature medicine. 2005;11(3):263&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">15723075</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds A, Anderson EM, Vermeulen A, Fedorov Y, Robinson K, Leake D, et al. Induction of the interferon response by siRNA is cell type&#x2013;and duplex length&#x2013;dependent. Rna. 2006;12(6):988&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1464853</ArticleId><ArticleId IdType="pubmed">16611941</ArticleId></ArticleIdList></Reference><Reference><Citation>Juliano R, Alam MR, Dixit V, Kang H. Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides. Nucleic Acids Research. 2008;36(12):4158&#x2013;71. 10.1093/nar/gkn342</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkn342</ArticleId><ArticleId IdType="pmc">PMC2475625</ArticleId><ArticleId IdType="pubmed">18558618</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo P, Coban O, Snead NM, Trebley J, Hoeprich S, Guo S, et al. Engineering RNA for targeted siRNA delivery and medical application. Adv Drug Deliv Rev. 2010;62(6):650&#x2013;66. Epub 2010/03/17. 10.1016/j.addr.2010.03.008 S0169-409X(10)00077-3 [pii].</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.addr.2010.03.008</ArticleId><ArticleId IdType="pmc">PMC2906696</ArticleId><ArticleId IdType="pubmed">20230868</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>